What Is NMN? A Complete Guide
What is NMN?
Last updated · Vitality Supplements Editorial Team · 10 min read
A complete guide to NMN — what it is, how it relates to NAD+, what the published research says, the doses used in human trials, where it stands with UK regulators, and what to look for when choosing an NMN supplement in the UK.
Food supplement ingredient guide · Not medical advice · No health claimsWhat is NMN?
NMN (Nicotinamide Mononucleotide) is a naturally occurring vitamin B3 derivative and a direct biosynthetic precursor to NAD+, the coenzyme present in every living cell. It is found in trace amounts in edamame, broccoli and avocado, and converts to NAD+ in one step via NMNAT enzymes in the salvage pathway. It is the most-studied NAD+ precursor: a 2023 systematic review of 10 randomised controlled trials with 437 participants found consistent blood NAD+ elevation at 250–900mg/day with no significant adverse events. NMN is widely sold as a food supplement ingredient in the UK; its regulatory position is not yet settled and it has no authorised health claims.
NMN is widely sold in the UK, but it is not yet authorised. A GB novel food application for β-NMN (FSA reference RP-2116) is under assessment by the Food Standards Agency. In the EU, EFSA published a positive safety opinion on β-NMN in 2026; formal EU authorisation is still pending and would not bind Great Britain in any case. No UK or EU health claim is authorised for NMN. We describe the published research on the compound; we make no health, medicinal or disease claims for any product.
- NMN is a vitamin B3 derivative and direct NAD+ precursor — one step from NAD+ via NMNAT enzymes
- NAD+ participates in over 500 enzymatic reactions and declines with age across multiple tissue types
- NMN has 30+ peer-reviewed human studies — the largest recent human research base of any NAD+ precursor
- A 2023 systematic review of 10 RCTs (437 participants) found consistent NAD+ elevation at 250–900mg/day
- GB novel food application RP-2116 is under FSA assessment; EFSA gave a positive opinion in 2026; no authorised health claims
- Quality criteria: >99% β-NMN purity, ISO/IEC 17025 batch testing, CoA on request, stated dose, stated origin
What is NMN?
NMN stands for Nicotinamide Mononucleotide. It is a naturally occurring compound found in trace amounts in a range of foods, including edamame, broccoli, cucumber and avocado. Chemically, NMN is a nucleotide — a type of molecule that serves as a building block for larger compounds in the body.
NMN belongs to the family of compounds known as vitamin B3 derivatives. Its primary role in human biochemistry is as a direct biosynthetic precursor to NAD+, a coenzyme present in every living cell and central to cellular metabolism. NMN was first identified as part of the NAD+ biosynthesis research initiated by Arthur Harden and William John Young in .
As a food supplement ingredient, NMN is widely sold in the United Kingdom. It does not have an authorised health claim under UK or EU regulations, meaning supplement brands are not permitted to make specific claims about what NMN does to the human body, and its novel food status is under assessment (see the regulatory note above). See our complete longevity supplements guide →
NMN is found naturally in foods including edamame, broccoli and avocado — though only in trace amounts.
NMN and NAD+
To understand why NMN is of interest as a supplement ingredient, it helps to first understand NAD+. See our complete What is NAD+? guide → and Longevity Protocol Pillar 1: NAD+ & Cellular Energy →
NAD+ is a coenzyme found in every living cell. It participates in hundreds of metabolic processes including the conversion of nutrients to energy, DNA repair signalling, and the activation of sirtuin enzymes that have been widely studied in longevity research. Published research has documented that NAD+ levels decline with age in human tissue across liver, skeletal muscle, heart and brain.
NMN enters this picture as a biosynthetic precursor — a smaller molecule that the body can use to produce NAD+ via the salvage pathway. Unlike NAD+ itself, which is a relatively large molecule with poor cellular uptake, NMN can be taken up by cells and used to produce NAD+ in one step by NMNAT enzymes.
NAD+ levels are documented to decline with age across multiple peer-reviewed studies — a finding reproduced in liver, muscle, heart and brain tissue.
NMN
NMNH
NR
What the research says
NMN has been the subject of extensive preclinical research over the past two decades, with a growing number of peer-reviewed human studies published since 2020. The following summarises the published research landscape — not as health claims, but as factual descriptions of what has been studied. For full references: research references →
Important note: The following describes what published research has investigated about NMN as a compound. These are not health claims for Vitality Supplements products. All Vitality Supplements products are food supplements and are not intended to diagnose, treat, cure or prevent any disease or medical condition.
The published human research base for NMN has grown substantially since 2020 — moving from primarily preclinical animal studies to peer-reviewed human trials.
NAD+ elevation
Multiple published peer-reviewed human studies have documented that NMN supplementation at doses ranging from 250mg to 900mg per day consistently elevated blood NAD+ levels in participants. A systematic review (Yi et al. 2023) covering 10 randomised controlled trials with 437 participants confirmed this finding, with no significant adverse events reported across studies. See the full NMN dosage guide →
Research areas
Published human research on NMN has investigated a range of areas including metabolic parameters, physical performance measures, sleep quality measures and various biomarkers of ageing. We describe these by study design rather than outcome, because summarising outcomes as benefits would itself be a health claim. Read the individual papers via our reference list or NMN clinical trials summary.
Safety profile
Human trials to date have not reported significant adverse events at doses up to 900mg per day. NMN is generally well tolerated in published research. Long-term safety data in humans is more limited than for some other supplement ingredients, which is one reason regulators are still assessing it. See NMN side effects & safety →
NMN dosing
NMN does not have an established recommended daily allowance (RDA) — it is a food supplement ingredient, not a nutrient with a formally established dietary reference value.
Published peer-reviewed human research on NMN has used doses in the range of 250mg to 900mg per day. Most published studies have used doses of 500mg or above. Vitality's NMN products provide between 500mg and 1000mg of NMN per serving; the 1000mg product sits above the highest dose used in the published trials to date, which is worth knowing when you choose. See the full NMN dosage guide with study-by-study breakdown → and NMN 500mg vs 1000mg →
Consult a qualified healthcare professional before starting NMN supplementation — particularly if you are pregnant, breastfeeding, taking prescription medication or have a pre-existing medical condition.
- 250–500mg/day: Lower end of doses studied in published human research. Used in several peer-reviewed trials.
- 500–750mg/day: Mid-range doses commonly used in published research protocols.
- 750–900mg/day: Highest doses studied in published human research. No significant adverse events reported.
- Timing: Most published research has used morning administration. No strong evidence exists for a specific optimal timing. See when to take NMN →
- With or without food: Published research has used both fasted and fed administration. No definitive guidance exists.
What to look for when buying NMN
The NMN supplement market in the UK varies significantly in quality. Here is what to look for and what to avoid. For the full buying guide: How to choose an NMN supplement → · For our ranked picks: Best NMN supplement UK →
- Purity verification: Look for greater than 99% β-NMN purity, verified by independent laboratory HPLC analysis — not just a general quality claim on the label.
- Independent batch testing: Every production batch should be tested by an independent ISO/IEC 17025-accredited laboratory. A Certificate of Analysis should be available on request.
- Stated dose: The exact milligram amount of NMN per serving should be clearly disclosed. Avoid proprietary blends that hide individual doses.
- β-NMN form: The biologically relevant form is β-NMN. Look for products that confirm the β form specifically.
- Manufacturing origin: Manufacturing origin should be clearly stated on packaging.
- Compliant claims: No health claim for NMN is authorised in the UK or EU. Brands making specific therapeutic claims are not compliant — and a brand that tells you NMN is "approved" or "not a novel food" is misinformed.
Vitality Supplements NMN: Greater than 99% β-NMN purity. Every batch independently tested by an ISO/IEC 17025-accredited laboratory. UK manufactured. Full dose disclosed. Certificate of Analysis available on request.
Vitality makes four standard-NMN formulas: NMN 1000mg Pure (single ingredient), NMN + Trans-Resveratrol 1100mg (500mg NMN + 600mg trans-resveratrol), NMN + TMG (750mg + 750mg) and NMN Complete (750mg NMN with TMG, pterostilbene and apigenin, 1600mg per two-capsule serving), plus the reduced form NMNH 500mg. All UK manufactured, third-party tested every batch. See every formula side by side →
Common questions
Shop Vitality NMN supplements
>99% β-NMN purity · UK manufactured · Every batch independently tested by an ISO/IEC 17025 laboratory · Certificate of Analysis on request